[24] [25] Tirzepatide (Mounjaro), a dual GIP/GLP-1 receptor agonist, has been approved for type 2 diabetes in the UK and shows even greater efficacy for both glucose control and weight loss
I would not recommend microdosing GLP-1s for individuals with significant amounts of weight to lose or known metabolic dysregulation. The bottom line is that there are still questions regarding the effectiveness and safety of microdosing GLP-1 medications, and this type of regimen is not for everyone
However, some people notice hair thinning, increased hair shedding, or thinning hair during treatment
Though HGH supplementation is banned in professional sports because its believed to give athletes an unfair edge in performance, the research on its benefits is mixed
The fact that the medication is injectable (meaning it is more rapidly absorbed) and its long half-life in the body (approximately 1 week), is another element that complicates things